Latest News and Press Releases

Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis

MONTRÉAL, March 17, 2026 (GLOBE NEWSWIRE) -- Troilus Mining Corp. (formerly Troilus Gold Corp.) (“Troilus” or the “Company”; TSX: TLG, OTCQX: CHXMF; FSE: CM5) is pleased to announce that it has...

Asimov partners with Score Pharma to develop biosuperior antibody therapeutics with enhanced ADCC activity using Asimov's CHO Edge platform.

TORONTO, March 17, 2026 (GLOBE NEWSWIRE) -- Guardian Capital LP (the “Manager”) announces the following regular cash distributions for the period ending March 31, 2026, in respect of the ETF series...

Lahontan Announces Upsize To Private Placement

Sam Asher is recognized for his leadership excellence in Aerospace & Defense GREENWICH, Conn., March 17, 2026 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play...

Q4 GAAP revenue of $104.5 million increased 317.7% year-over-year, driven by recently closed M&A transactions On a pro forma basis, Q4 same store sales increased 22% year-over-year and wholesale...

OTTAWA, Ontario, March 17, 2026 (GLOBE NEWSWIRE) -- Telesat (Nasdaq and TSX: TSAT), one of the world’s largest and most innovative satellite operators, today announced its financial results for the...

TUCSON, Ariz., March 17, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial...

Monte Rosa Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates